GENinCode Plc (LON:GENI – Get Free Report)’s stock price fell 2.1% on Thursday . The stock traded as low as GBX 4 ($0.05) and last traded at GBX 4.02 ($0.05). 90,092 shares traded hands during mid-day trading, a decline of 92% from the average session volume of 1,074,552 shares. The stock had previously closed at GBX 4.10 ($0.05).
GENinCode Price Performance
The company has a market cap of £7.26 million, a price-to-earnings ratio of -82.00 and a beta of 0.66. The company has a current ratio of 2.60, a quick ratio of 15.89 and a debt-to-equity ratio of 9.27. The stock’s 50-day moving average is GBX 3.86 and its 200-day moving average is GBX 5.01.
About GENinCode
GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.
GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.
See Also
- Five stocks we like better than GENinCode
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Must-Have ETFs Set to Dominate This Quarter
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Seeking Stability? These 3 Stocks Offer Strong Potential
- 3 REITs to Buy and Hold for the Long Term
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
